Article

CIBA Vision sells Epi-LASIK devices to Australian firm

CIBA Vision Corp., Atlanta, on May 3 sold its Epi-LASIK surgical product line to Norwood Abbey Ltd., a medical devices company based in Australia.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Jason Bacharach, MD, on early-onset efficacy with perfluorohexyloctane in dry eye
(Image credit: Ophthalmology Times) CCOI's new CEO Malvina Eydelman, MD, outlines her mission and vision for the organization
CIME 2025: Neda Shamie, MD, on expanding options in pharmacological presbyopia management
Related Content
OCTA role in retinal microvascular changes in SLE patients
May 13th 2025

OCTA role in retinal microvascular changes in SLE patients

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Potentially hazardous eye care products recalled nationwide
May 12th 2025

Potentially hazardous eye care products recalled nationwide

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Q&A: Carl D. Regillo, MD, shares updates on the VERONA trial for DME
May 10th 2025

Q&A: Carl D. Regillo, MD, shares updates on the VERONA trial for DME

Monique Barbour, MD, highlights benefits of dropless protocol over traditional drops
May 10th 2025

Monique Barbour, MD, highlights benefits of dropless protocol over traditional drops

© 2025 MJH Life Sciences

All rights reserved.